DrugCombination product
Extended Release Dosage Form clinical trials
- studies test it
- 3
- open now
- 1
- in phase 3
- 0
- first study started
- 2016
Keep track of what changes. Save the Extended Release Dosage Form studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2021 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · Ain Shams University (1)
Often tested with
Tested in the same studies.
Indomethacin (1) · Oral Capsule Dosage Form (1) · Etoricoxib (1) · 4-Aminopyridine (1) · Oral Tablet Dosage Form (1)
Studies
Open first, then newest update. How each study uses Extended Release Dosage Form is read from its arms, and is right about nine times in ten.
Testing it · 3
- Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKANot yet recruitingPhase 4Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07430085Written as bupivacaine-meloxicam (extended release)
- Dalfampridine in Egyptian Patients With Multiple SclerosisStatus unknownNot applicableAin Shams UniversityNCT05730738Written as Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
- Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis PatientsCompletedPhase 4Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshNCT03582332Written as Indomethacin SR, 75 Mg Oral Capsule, Extended Release